14
Participants
Start Date
September 30, 2012
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2017
Ranolazine
The intervention will be ranolazine therapy after the initial CPET. The initial CPET will identify patients with underlying ischemia and serve as a baseline study. Patients whose CPET results meet the criteria for ischemia will be started on Ranexa 500mg BID and advanced within one week +/-4 days to 1000mg BID. A second CPET will be performed after 4 weeks +/- 4 days of maximum therapy. CPET results before and after therapy will undergo a statistical comparison. The initial off treatment CPET measurement will serve as the control to assess changes found during therapy.
Cardiovascular Institute of the South, Lafayette
Collaborators (1)
Gilead Sciences
INDUSTRY
Cardiovascular Institute of the South Clinical Research Corporation
OTHER